<DOC>
	<DOC>NCT00966641</DOC>
	<brief_summary>The purpose of this study is to determine the single-dose pharmacokinetics of the investigational drug PL 3100 following oral administration to healthy volunteers and to compare the pharmacokinetic profiles of PL 3100 and naproxen at a prescription dose.</brief_summary>
	<brief_title>Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>Age 1875 years, inclusive. Subject has a Body Mass Index (BMI) between 20 and 32, inclusive. Normal physical examination as determined by the Investigator. Normal clinical laboratory test results or clinically insignificant results as determined by the Investigator during the screening visit. If female and of childbearing potential, the subject must have a negative pregnancy test and is not nursing. If female and of childbearing potential, the subject must agree to use adequate birth control for the duration of the study. Subject has a history of chronic alcohol consumption or abuse of narcotics or alcohol. Subject has had an acute illness within 5 days of study medication administration. Subject is currently participating, or has participated within 30 days prior to study entry, in an investigational drug study. Subject has hypersensitivity or contraindications to naproxen, ibuprofen, or other NSAID.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>